mhurhangee/ep-ind-claims huggingface dataset:
A medical device for implantation in a hip joint of a human patient, the natural hip joint having a ball shaped caput femur as the proximal part of the femoral bone with a convex hip joint surface towards the center of the hip joint and a bowl shaped acetabulum as part of the pelvic bone with a concave hip joint surface towards the center of the hip joint, the medical device comprising; an artificial caput femur, comprising a convex surface towards the center of the hip joint, wherein said artificial convex caput femur is adapted to, when implanted: a. be fixated to the pelvic bone of the human patient, and b. be in movable connection with an artificial acetabulum surface fixated to the femoral bone of the patient, thereby forming a ball and socket joint, wherein the medical device further comprises a fixation element for fixating the medical device to the pelvic bone, wherein the fixation element comprises a fixation surface adapted to fit into the acetabulum of the pelvic bone, characterized in that the medical device comprises an elongated member adapted to be inserted into a hole in the pelvic bone, and in that the elongated member is adapted to be structurally changed on the abdominal side of the pelvic bone, such that it fixates the fixation element to the pelvic bone when implanted. an artificial caput femur, comprising a convex surface towards the center of the hip joint, wherein said artificial convex caput femur is adapted to, when implanted: a. be fixated to the pelvic bone of the human patient, and b. be in movable connection with an artificial acetabulum surface fixated to the femoral bone of the patient, thereby forming a ball and socket joint, a. be fixated to the pelvic bone of the human patient, and b. be in movable connection with an artificial acetabulum surface fixated to the femoral bone of the patient, thereby forming a ball and socket joint, wherein the medical device further comprises a fixation element for fixating the medical device to the pelvic bone, wherein the fixation element comprises a fixation surface adapted to fit into the acetabulum of the pelvic bone, characterized in that the medical device comprises an elongated member adapted to be inserted into a hole in the pelvic bone, and in that the elongated member is adapted to be structurally changed on the abdominal side of the pelvic bone, such that it fixates the fixation element to the pelvic bone when implanted.
An additive manufacturing build material container comprising a reservoir to hold build material including an upper portion of more than half the height of the reservoir, having relatively non-converging side walls, a lower portion between the upper portion and a bottom, having converging side walls, at least in a filled state; and a build material outlet structure to allow build material to exit the reservoir, wherein the outlet structure includes an outlet opening in a top portion of the reservoir, wherein the outlet structure includes an adaptor (251, 451, 651, 751) to connect to and disconnect from an external collection system, the adaptor (251, 451) including an interface face around the outlet opening, approximately perpendicular to an air or build material flow direction, wherein at least one guide feature and a data interface are provided in the interface face, and wherein the data interface is to communicate build material parameters to a second data interface, of the collection system, when the adaptor (251, 451, 651, 751) is connected to the collecting system. a reservoir to hold build material including an upper portion of more than half the height of the reservoir, having relatively non-converging side walls, a lower portion between the upper portion and a bottom, having converging side walls, at least in a filled state; and an upper portion of more than half the height of the reservoir, having relatively non-converging side walls, a lower portion between the upper portion and a bottom, having converging side walls, at least in a filled state; and a build material outlet structure to allow build material to exit the reservoir, wherein the outlet structure includes an outlet opening in a top portion of the reservoir, wherein the outlet structure includes an adaptor (251, 451, 651, 751) to connect to and disconnect from an external collection system, the adaptor (251, 451) including an interface face around the outlet opening, approximately perpendicular to an air or build material flow direction, wherein at least one guide feature and a data interface are provided in the interface face, and wherein the data interface is to communicate build material parameters to a second data interface, of the collection system, when the adaptor (251, 451, 651, 751) is connected to the collecting system. wherein the outlet structure includes an outlet opening in a top portion of the reservoir, wherein the outlet structure includes an adaptor (251, 451, 651, 751) to connect to and disconnect from an external collection system, the adaptor (251, 451) including an interface face around the outlet opening, approximately perpendicular to an air or build material flow direction, wherein at least one guide feature and a data interface are provided in the interface face, and wherein the data interface is to communicate build material parameters to a second data interface, of the collection system, when the adaptor (251, 451, 651, 751) is connected to the collecting system.
A multiple space vehicle launch system, comprising: a first space vehicle; a second space vehicle releasably attached to the first space vehicle and oriented relative to the first space vehicle such that when placed within a fairing, a launch load from the first space vehicle is transmitted to and borne by the second space vehicle; wherein the first space vehicle includes a first electrical propulsion unit and wherein the second space vehicle includes a second electrical propulsion unit, wherein the first space vehicle includes a first core structure and the second space vehicle includes a second core structure, wherein the first core structure is attached to the second core structure, and wherein the launch load from the first space vehicle is transmitted to the second space vehicle through the first core structure and the second core structure; wherein the first space vehicle includes a first shear load panel mounted on the first core structure and a deployable solar array supported by the first shear load panel, and wherein the second space vehicle includes a second shear load panel mounted on the second core structure and a second deployable solar array supported by the second shear load panel. a first space vehicle; a second space vehicle releasably attached to the first space vehicle and oriented relative to the first space vehicle such that when placed within a fairing, a launch load from the first space vehicle is transmitted to and borne by the second space vehicle; wherein the first space vehicle includes a first electrical propulsion unit and wherein the second space vehicle includes a second electrical propulsion unit, wherein the first space vehicle includes a first core structure and the second space vehicle includes a second core structure, wherein the first core structure is attached to the second core structure, and wherein the launch load from the first space vehicle is transmitted to the second space vehicle through the first core structure and the second core structure; wherein the first space vehicle includes a first shear load panel mounted on the first core structure and a deployable solar array supported by the first shear load panel, and wherein the second space vehicle includes a second shear load panel mounted on the second core structure and a second deployable solar array supported by the second shear load panel.
A process for the production of polyunsaturated fatty acids in an organism, which comprises the following steps: a) introducing, into the organism, at least one nucleic acid sequence with the sequence shown in SEQ ID NO: 20, which codes for a polypeptide with lysophosphatidic acid acyltransferase activity; or b) introducing, into the organism, at least one nucleic acid which can be derived from the coding sequence in SEQ ID NO: 20 as the result of the degeneracy of the genetic code, or c) introducing, into the organism, at least one derivative of the nucleic acid shown in SEQ ID NO: 20 which codes for a polypeptide which has at least 60% homology at the amino acid level with the amino acid sequence shown in SEQ ID NO: 21 and which has a lysophosphatidic acid acyltransferase activity, and d) culturing and harvesting the organism, wherein the organism is a microorganism, a plant, a plant seed or a plant cell. a) introducing, into the organism, at least one nucleic acid sequence with the sequence shown in SEQ ID NO: 20, which codes for a polypeptide with lysophosphatidic acid acyltransferase activity; or b) introducing, into the organism, at least one nucleic acid which can be derived from the coding sequence in SEQ ID NO: 20 as the result of the degeneracy of the genetic code, or c) introducing, into the organism, at least one derivative of the nucleic acid shown in SEQ ID NO: 20 which codes for a polypeptide which has at least 60% homology at the amino acid level with the amino acid sequence shown in SEQ ID NO: 21 and which has a lysophosphatidic acid acyltransferase activity, and d) culturing and harvesting the organism,
A method of bulk encoding RFID tags, comprising the following consecutive steps: printing desired indicia on a plurality of unencoded RFID tags, the indicia corresponding to desired product or manufacturer information; coupling each of the plurality of unencoded RFID tags to each of a plurality of products; sorting the products to ensure that all desired products are coupled with RFID tags and that each container exclusively contains the same or similar type of products; packaging the same or similar type of product from the plurality products coupled with the unencoded RFID tags together in a container; scanning the container holding the plurality of products with at least one RFID antenna for encoding each of the unencoded RFID tags within each container with identical information; and scanning in bulk to determine that all the encoded RFID tags within the container are encoded with identical information, wherein the plurality of containers are transported by a conveyor past the at least one RFID antenna at a speed that is adjusted based on a type of the unencoded RFID tags and/or a number of products in the container. printing desired indicia on a plurality of unencoded RFID tags, the indicia corresponding to desired product or manufacturer information; coupling each of the plurality of unencoded RFID tags to each of a plurality of products; sorting the products to ensure that all desired products are coupled with RFID tags and that each container exclusively contains the same or similar type of products; packaging the same or similar type of product from the plurality products coupled with the unencoded RFID tags together in a container; scanning the container holding the plurality of products with at least one RFID antenna for encoding each of the unencoded RFID tags within each container with identical information; and scanning in bulk to determine that all the encoded RFID tags within the container are encoded with identical information, wherein the plurality of containers are transported by a conveyor past the at least one RFID antenna at a speed that is adjusted based on a type of the unencoded RFID tags and/or a number of products in the container.
A method of increasing drought tolerance in a plant comprising applying a composition to the plant in an amount effective for increasing drought tolerance in the plant, wherein the composition comprises an isolated culture of Enterobacter sp. 638.
An atherectomy catheter comprising: a body having an opening; a rotatable shaft coupled to the body; a cutting element coupled to the rotatable shaft for rotating the cutting element about an axis of rotation, the cutting element having a cup-shaped surface and a cutting edge, the cup-shaped surface being configured to re-direct tissue cut by the cutting edge in a distal direction when the cup-shaped surface moves in the distal direction; a tissue collection chamber coupled to the body and positioned distal to the cutting element; and a raised element extending outwardly from the cup-shaped surface of the cutting element, the raised element comprising a curved first wall extending from the cup-shaped surface, a second wall, a third wall extending between radially inner portions of the first and second walls (30B, 32B), a distal wall, and a curved raised element cutting edge formed at the intersection of the curved first wall and the distal wall, characterised in that the curved first wall of the raised element is configured to create a fluid vortex when the cutting element is rotated, which directs cut particles of material towards the axis of rotation of the cutting element. a body having an opening; a rotatable shaft coupled to the body; a cutting element coupled to the rotatable shaft for rotating the cutting element about an axis of rotation, the cutting element having a cup-shaped surface and a cutting edge, the cup-shaped surface being configured to re-direct tissue cut by the cutting edge in a distal direction when the cup-shaped surface moves in the distal direction; a tissue collection chamber coupled to the body and positioned distal to the cutting element; and a raised element extending outwardly from the cup-shaped surface of the cutting element, the raised element comprising a curved first wall extending from the cup-shaped surface, a second wall, a third wall extending between radially inner portions of the first and second walls (30B, 32B), a distal wall, and a curved raised element cutting edge formed at the intersection of the curved first wall and the distal wall,
Locking device having a guard lock for safety doors, comprising a mechanical actuator which can be fastened on a movable door part and a housing which interacts with the actuator and can be fastened to a door counterpart, which housing comprises a receptor to which the actuator can be inserted, and the housing comprises a locking member which is displaceable between an unlocked position, in which the actuator can be released, and a locked position, in which the actuator can be fixed relative to the receptor, wherein the actuator comprises an engagement tongue having an engagement recess for a mechanical operative engagement with a head end of a locking member in form of an engagement plunger, the engagement plunger being guided in the housing so as to be longitudinally displaceable in a spring-biased manner in a plunger longitudinal direction relative to an inner, bush-shaped fixed bearing which carries radially displaceable and fixable engagement elements which lock the engagement plunger at its inner contour in the locked position during a defined state, for which purpose the engagement plunger comprises an engagement stop at the inner contour, which acts in the longitudinal direction, characterized in that the engagement tongue is provided with an electronic identification element, and the housing comprises a sensor device for detecting the electronic identification element in an area of the receptor.
A method of removing a core of a cast component, comprising: providing a casting that includes a silica based ceramic core in a temperature controlled closed volume; cycling temperature between a first temperature (T 1) and a second temperature (T 2) within the temperature controlled closed volume that repeatedly subjects the silica based ceramic core to a beta-to-alpha cristobalite transition that induces microfractures in the silica based ceramic core; and after the cycling temperature, chemically dissolving the silica based ceramic core from the casting. providing a casting that includes a silica based ceramic core in a temperature controlled closed volume; cycling temperature between a first temperature (T 1) and a second temperature (T 2) within the temperature controlled closed volume that repeatedly subjects the silica based ceramic core to a beta-to-alpha cristobalite transition that induces microfractures in the silica based ceramic core; and after the cycling temperature, chemically dissolving the silica based ceramic core from the casting.
A heterofunctional poly(alkyleneoxide) having a poly(alkyleneoxide) backbone and first and second polymer termini, wherein the first polymer terminus comprises a protected, unprotected, or derivatized aminoalkyl functionality and the second polymer terminus comprises an olefinic functionality, wherein the protected aminoalkyl functionality comprises a silylated amine group, the unprotected aminoalkyl functionality comprises an α-amine or α-aminoalkyl group, and the derivatized aminoalkyl functionality comprises an amide or N-substituted urea group, and wherein the olefinic functionality is coupled to the poly(alkyleneoxide) backbone by an ether linkage.
A food preparation device comprising: a container suitable for receiving food for preparation, the container presenting a bottom and a side wall that rises from the bottom generally along a vertical axis, at least two blades (10, 11, 12, 13) arranged in the container, each blade (10, 11, 12, 13) being driven in rotation about an axis of rotation (R1, R2; R3, R4), the axis of rotation of at least one of the blades (10; 11; 12; 13) extending in the direction of said vertical axis, characterized in that the axis of rotation (R1, R3, R4) of at least one of the other blades (10, 11, 12, 13) is inclined at a non-zero angle of inclination (I1, 13, 14) relative to said vertical axis. a container suitable for receiving food for preparation, the container presenting a bottom and a side wall that rises from the bottom generally along a vertical axis, at least two blades (10, 11, 12, 13) arranged in the container, each blade (10, 11, 12, 13) being driven in rotation about an axis of rotation (R1, R2; R3, R4), the axis of rotation of at least one of the blades (10; 11; 12; 13) extending in the direction of said vertical axis,
A motorcycle comprising: a fuel tank for storing fuel; a fuel filling joint hydraulically connected to the fuel tank; a first pressure reducing valve hydraulically connected to the fuel tank to reduce pressure of the fuel to first pressure; a second pressure reducing valve hydraulically connected to the first pressure reducing valve to reduce the pressure of the fuel to second pressure; a fuel cell unit hydraulically connected to the second pressure reducing valve to generate electric power via reaction of the fuel and an oxidizing agent; a high-pressure side structure that supports the fuel tank, the joint, and the first pressure reducing valve while keeping relative arrangement thereof so as to configure a high-pressure side module; a low-pressure side structure that supports the second pressure reducing valve and the fuel cell unit while keeping relative arrangement thereof so as to configure a low-pressure side module; and a main structure that detachably fixes the high-pressure side structure and the low-pressure side structure, characterized in that the high-pressure side module and the low-pressure side module are removable from the main structure in such a way that they are inspectable separately from each other. a fuel tank for storing fuel; a fuel filling joint hydraulically connected to the fuel tank; a first pressure reducing valve hydraulically connected to the fuel tank to reduce pressure of the fuel to first pressure; a second pressure reducing valve hydraulically connected to the first pressure reducing valve to reduce the pressure of the fuel to second pressure; a fuel cell unit hydraulically connected to the second pressure reducing valve to generate electric power via reaction of the fuel and an oxidizing agent; a high-pressure side structure that supports the fuel tank, the joint, and the first pressure reducing valve while keeping relative arrangement thereof so as to configure a high-pressure side module; a low-pressure side structure that supports the second pressure reducing valve and the fuel cell unit while keeping relative arrangement thereof so as to configure a low-pressure side module; and a main structure that detachably fixes the high-pressure side structure and the low-pressure side structure, characterized in that the high-pressure side module and the low-pressure side module are removable from the main structure in such a way that they are inspectable separately from each other.
A photoactivatable drug for use in treating a subject with a disorder, said use comprising: providing within the subject at least one photoactivatable drug for treatment of the subject; applying initiation energy from at least one source to generate inside the subject a preferential x-ray flux for generation of Cherenkov radiation light capable of activating the at least one photoactivatable drug; and from said CR light, activating inside the subject the at least one photoactivatable drug to thereby treat the disorder, wherein applying initiation energy comprises applying a filtered set of x-rays to the subject having an energy of at least 0.5 MeV and less than 10 MeV. providing within the subject at least one photoactivatable drug for treatment of the subject; applying initiation energy from at least one source to generate inside the subject a preferential x-ray flux for generation of Cherenkov radiation light capable of activating the at least one photoactivatable drug; and from said CR light, activating inside the subject the at least one photoactivatable drug to thereby treat the disorder, wherein applying initiation energy comprises applying a filtered set of x-rays to the subject having an energy of at least 0.5 MeV and less than 10 MeV.
The compound 3'-[ -[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid or a pharmaceutically acceptable salt thereof,for use in treating thrombocytopenia, neutropenia, and/or for increasing platelet production in a human in need thereof by administering a load dose of the compound. Wherein the load dose of the compound, pharmaceutically acceptable salt thereof, is an amount ranging from about 50 mg to about 150 mg administered from 2 to 4 times in a day for from 1 to 14 days, or is an amount ranging from about 200 mg to about 600 mg administered once a day for from 1 to 14 days, is followed by the administration of a maintenance dose of the compound, or pharmaceutically acceptable salt thereof, wherein the maintenance dose of the compound, or pharmaceutically acceptable salt thereof, is an amount of from about 25 mg to about 150 mg a day for at least two additional days. Wherein the load dose of the compound, pharmaceutically acceptable salt thereof, is an amount ranging from about 50 mg to about 150 mg administered from 2 to 4 times in a day for from 1 to 14 days, or is an amount ranging from about 200 mg to about 600 mg administered once a day for from 1 to 14 days, is followed by the administration of a maintenance dose of the compound, or pharmaceutically acceptable salt thereof, wherein the maintenance dose of the compound, or pharmaceutically acceptable salt thereof, is an amount of from about 25 mg to about 150 mg a day for at least two additional days.